Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of an Intravenous Staphylococcus Aureus Immune Globulin (Human), [Altastaph] in Low-Birth-Weight-Neonates
This study has been completed.
Study NCT00066989   Information provided by Nabi Biopharmaceuticals
First Received: August 8, 2003   Last Updated: July 11, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Staphylococcal Infections
Additional conditions recognized in this trial
Birth Weight
Communicable Diseases
Infection
More general conditions related to this trial
Bacterial Infections
Body Weight
Gram-Positive Bacterial Infections
Signs and Symptoms
Additional drug interventions recognized in this trial
Antibodies
Immunoglobulins
More general drug interventions related to this trial
Immunologic Factors
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Nabi Biopharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services